185 related articles for article (PubMed ID: 33887527)
1. Ribosomal proteins as distinct "passengers" of microvesicles: new semantics in myeloma and mesenchymal stem cells' communication.
Dabbah M; Lishner M; Jarchowsky-Dolberg O; Tartakover-Matalon S; Brin YS; Pasmanik-Chor M; Neumann A; Drucker L
Transl Res; 2021 Oct; 236():117-132. PubMed ID: 33887527
[TBL] [Abstract][Full Text] [Related]
2. Mesenchymal stem cells secretomes' affect multiple myeloma translation initiation.
Marcus H; Attar-Schneider O; Dabbah M; Zismanov V; Tartakover-Matalon S; Lishner M; Drucker L
Cell Signal; 2016 Jun; 28(6):620-30. PubMed ID: 26976208
[TBL] [Abstract][Full Text] [Related]
3. Microvesicles derived from normal and multiple myeloma bone marrow mesenchymal stem cells differentially modulate myeloma cells' phenotype and translation initiation.
Dabbah M; Attar-Schneider O; Tartakover Matalon S; Shefler I; Jarchwsky Dolberg O; Lishner M; Drucker L
Carcinogenesis; 2017 Jul; 38(7):708-716. PubMed ID: 28838065
[TBL] [Abstract][Full Text] [Related]
4. Multiple myeloma BM-MSCs increase the tumorigenicity of MM cells via transfer of VLA4-enriched microvesicles.
Dabbah M; Jarchowsky-Dolberg O; Attar-Schneider O; Tartakover Matalon S; Pasmanik-Chor M; Drucker L; Lishner M
Carcinogenesis; 2020 Mar; 41(1):100-110. PubMed ID: 31586190
[TBL] [Abstract][Full Text] [Related]
5. Niche origin of mesenchymal stem cells derived microvesicles determines opposing effects on NSCLC: Primary versus metastatic.
Attar-Schneider O; Dabbah M; Drucker L; Gottfried M
Cell Signal; 2020 Jan; 65():109456. PubMed ID: 31672605
[TBL] [Abstract][Full Text] [Related]
6. BM-MSCs-derived ECM modifies multiple myeloma phenotype and drug response in a source-dependent manner.
Ibraheem A; Attar-Schneider O; Dabbah M; Dolberg Jarchowsky O; Tartakover Matalon S; Lishner M; Drucker L
Transl Res; 2019 May; 207():83-95. PubMed ID: 30738861
[TBL] [Abstract][Full Text] [Related]
7. Multiple myeloma and bone marrow mesenchymal stem cells' crosstalk: Effect on translation initiation.
Attar-Schneider O; Zismanov V; Dabbah M; Tartakover-Matalon S; Drucker L; Lishner M
Mol Carcinog; 2016 Sep; 55(9):1343-54. PubMed ID: 26293751
[TBL] [Abstract][Full Text] [Related]
8. Multiple myeloma cells promote migration of bone marrow mesenchymal stem cells by altering their translation initiation.
Dabbah M; Attar-Schneider O; Zismanov V; Tartakover Matalon S; Lishner M; Drucker L
J Leukoc Biol; 2016 Oct; 100(4):761-770. PubMed ID: 27272311
[TBL] [Abstract][Full Text] [Related]
9. Secretome of human bone marrow mesenchymal stem cells: an emerging player in lung cancer progression and mechanisms of translation initiation.
Attar-Schneider O; Zismanov V; Drucker L; Gottfried M
Tumour Biol; 2016 Apr; 37(4):4755-65. PubMed ID: 26515338
[TBL] [Abstract][Full Text] [Related]
10. Serum deprivation elevates the levels of microvesicles with different size distributions and selectively enriched proteins in human myeloma cells in vitro.
Sun L; Wang HX; Zhu XJ; Wu PH; Chen WQ; Zou P; Li QB; Chen ZC
Acta Pharmacol Sin; 2014 Mar; 35(3):381-93. PubMed ID: 24374813
[TBL] [Abstract][Full Text] [Related]
11. Isolation and characterization of microvesicles from mesenchymal stem cells.
Mohammadi MR; Riazifar M; Pone EJ; Yeri A; Van Keuren-Jensen K; Lässer C; Lotvall J; Zhao W
Methods; 2020 May; 177():50-57. PubMed ID: 31669353
[TBL] [Abstract][Full Text] [Related]
12. BCR-ABL1-positive microvesicles malignantly transform human bone marrow mesenchymal stem cells in vitro.
Fu FF; Zhu XJ; Wang HX; Zhang LM; Yuan GL; Chen ZC; Li QB
Acta Pharmacol Sin; 2017 Nov; 38(11):1475-1485. PubMed ID: 28836580
[TBL] [Abstract][Full Text] [Related]
13. Suppression of Ovarian Cancer Cell Growth by AT-MSC Microvesicles.
Szyposzynska A; Bielawska-Pohl A; Krawczenko A; Doszyn O; Paprocka M; Klimczak A
Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33266317
[TBL] [Abstract][Full Text] [Related]
14. BM-MSCs-derived microvesicles promote allogeneic kidney graft survival through enhancing micro-146a expression of dendritic cells.
Wu XQ; Yan TZ; Wang ZW; Wu X; Cao GH; Zhang C
Immunol Lett; 2017 Nov; 191():55-62. PubMed ID: 28963073
[TBL] [Abstract][Full Text] [Related]
15. The Role of Microvesicles Derived from Mesenchymal Stem Cells in Lung Diseases.
Chen J; Li C; Chen L
Biomed Res Int; 2015; 2015():985814. PubMed ID: 26064975
[TBL] [Abstract][Full Text] [Related]
16. Microvesicles derived from human umbilical cord mesenchymal stem cells ameliorate renal ischemia-reperfusion injury via delivery of miR-21.
Du T; Zhou J; Chen WX; Zhang XL; Ji TY; Liu J; Rong L; Wang LD; Zhou RJ; Ding DG
Cell Cycle; 2020 Jun; 19(11):1285-1297. PubMed ID: 32329653
[TBL] [Abstract][Full Text] [Related]
17. Microvescicles derived from mesenchymal stromal cells are not as effective as their cellular counterpart in the ability to modulate immune responses in vitro.
Conforti A; Scarsella M; Starc N; Giorda E; Biagini S; Proia A; Carsetti R; Locatelli F; Bernardo ME
Stem Cells Dev; 2014 Nov; 23(21):2591-9. PubMed ID: 24937591
[TBL] [Abstract][Full Text] [Related]
18. Differentially expressed microRNAs in bone marrow mesenchymal stem cell-derived microvesicles in young and older rats and their effect on tumor growth factor-β1-mediated epithelial-mesenchymal transition in HK2 cells.
Wang Y; Fu B; Sun X; Li D; Huang Q; Zhao W; Chen X
Stem Cell Res Ther; 2015 Sep; 6():185. PubMed ID: 26415502
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of mesenchymal stem cell-derived microvesicles in mouse inflammatory arthritis.
Wei S; Lu C; Li S; Zhang Q; Cheng R; Pan S; Wu Q; Zhao X; Tian X; Zeng X; Liu Y
Int Immunopharmacol; 2024 Apr; 131():111845. PubMed ID: 38531171
[TBL] [Abstract][Full Text] [Related]
20. Tumor Cell-Derived Microvesicles Induced Not Epithelial-Mesenchymal Transition but Apoptosis in Human Proximal Tubular (HK-2) Cells: Implications for Renal Impairment in Multiple Myeloma.
Zhao A; Kong F; Liu CJ; Yan G; Gao F; Guo H; Guo AY; Chen Z; Li Q
Int J Mol Sci; 2017 Feb; 18(3):. PubMed ID: 28264449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
